Take 5 minutes to catch up on NeurologyLive's highlights from the week ending October 8, 2021.
Welcome to NeurologyLive's Friday 5! Every week, the staff compiles 5 highlights of NeurologyLive's widespread coverage in neurology, ranging from newsworthy study findings and FDA action to expert interviews and peer-to-peer panel discussions.
In the fourth session of the "Managing Multiple Sclerosis: A Team Approach," put on in collaboration with the Consortium of MS Centers and International Organization of MS Rehabilitation Therapists, Patty Bobryk, PT, and Christine Smith, OT, engaged in expert discussion on fatigue management and cognitive impairment.
The assistant professor in the division of pulmonary, critical care, and sleep medicine at the University of Washington discussed patients’ response to the use of telehealth when treating sleep disorders and findings from a recent study, which recruited participants with sleep disorders between June 2019 and May 2020, all of whom had 1 of 3 types of telehealth encounters—in-clinic video, home-based video, or telephone. [WATCH TIME: 2 minutes]
The expert medical director at Roche provided context on recently published data, which showed prasinezumab’s positive impact in delaying motor progression in patients with Parkinson disease (PD), specifically the analysis of part 2 of the phase 2 PASADENA study (NCT03100149), which evaluated the efficacy and safety of prasinezumab in patients with early-stage PD.
"Mind Moments," a podcast from NeurologyLive, brings you an exclusive interview with Gregory W. Albers, MD, director, Stanford Stroke Center, and Coyote Foundation Professor of Neurology and Neurological Sciences, Stanford Medical Center. He shared his insight into the development and clinical use of RapidAI, a platform that leverages artificial intelligence to create enhanced, high-quality images from noncontrast CT, CT angiography, CT perfusion, and MRI diffusion and perfusion data, aiming to expedient diagnoses, treatment, and transfer decisions.
In Episode 6 of the NeurologyLive Peer Exchange series, "Managing Neuromyelitis Optica Spectrum Disorders (NMOSD)," Brian G. Weinshenker, MD, detailed what clinicians should know about treating patients with neuromyelitis optica spectrum disorders throughout the COVID-19 pandemic.
Recognize and celebrate the individuals who have achieved landmark successes within multiple sclerosis! Giants of Multiple Sclerosis™ is a premier neuroscience award that celebrates pioneers, innovators, and future generations of leaders who have been selected by their peers for their remarkable achievements in Multiple Sclerosis.
More information will be announced at a welcome reception during the 2021 Consortium of MS Centers Annual Meeting.
Aren't registered for the 2021 CMSC Annual Meeting? Register now.